| scholarly article | Q13442814 |
| P50 | author | Jack W. Kent | Q47502987 |
| Clayton W Commander | Q52955341 | ||
| Scott M Blackman | Q56867504 | ||
| John Blangero | Q66732805 | ||
| P2093 | author name string | Wei Sun | |
| Lei Sun | |||
| Michael R Knowles | |||
| David Cutler | |||
| Garry R Cutting | |||
| Peter R Durie | |||
| Fei Zou | |||
| Fred A Wright | |||
| Chelsea Taylor | |||
| Jaclyn R Stonebraker | |||
| Mary Corey | |||
| Mitchell L Drumm | |||
| Rhonda G Pace | |||
| Wanda K O'Neal | |||
| Julian Zielenski | |||
| Ethan M Lange | |||
| Weili Li | |||
| Johanna M Rommens | |||
| Katrina Goddard | |||
| Ruslan Dorfman | |||
| Seunggeun Lee | |||
| Vishal K Doshi | |||
| J Michael Collaco | |||
| Jingchun Luo | |||
| Yves Berthiaume | |||
| Lisa J Strug | |||
| Andrew Sandford | |||
| Andreea Cojocaru | |||
| Deanna Green | |||
| Kathleen M Naughton | |||
| Lori L Vanscoy | |||
| Gregory M Mayhew | |||
| Peter Paré | |||
| P2860 | cites work | A comprehensive functional analysis of tissue specificity of human gene expression | Q21245339 |
| ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1 | Q22011151 | ||
| Spirometric reference values from a sample of the general U.S. population | Q23915196 | ||
| Genome-wide association study identifies five loci associated with lung function | Q24629653 | ||
| CAS proteins in normal and pathological cell growth control | Q24630247 | ||
| Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function | Q24633262 | ||
| Modifier genes in Mendelian disorders: the example of cystic fibrosis | Q37822861 | ||
| Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation | Q39982882 | ||
| Integrated study of copy number states and genotype calls using high-density SNP arrays | Q41890841 | ||
| A role for MC3R in modulating lung inflammation | Q44501773 | ||
| Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis | Q44923126 | ||
| Pulmonary function between 6 and 18 years of age. | Q46340194 | ||
| Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. | Q47230840 | ||
| Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium. | Q47874582 | ||
| Energy balance in cystic fibrosis when stable and during a respiratory exacerbation | Q47892706 | ||
| Resting energy expenditure and lung disease in cystic fibrosis | Q47918043 | ||
| Disease-specific reference equations for lung function in patients with cystic fibrosis. | Q51970737 | ||
| Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. | Q53761963 | ||
| A direct approach to false discovery rates | Q56622258 | ||
| Genetic and environmental influences on pulmonary function in aging Swedish twins | Q57278183 | ||
| Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies | Q57591588 | ||
| Prolonged survival of neutrophils from patients with F508 CFTR mutations | Q60129183 | ||
| Genetic and environmental influences on pulmonary function in adult twins | Q70675879 | ||
| Correlation between genotype and phenotype in patients with cystic fibrosis | Q72383694 | ||
| Genetic modifiers of lung disease in cystic fibrosis | Q81316734 | ||
| The melanocortin system and energy balance | Q24645137 | ||
| HEF1-dependent Aurora A activation induces disassembly of the primary cilium | Q24647111 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Patient counseling about herbal-drug interactions | Q27691281 | ||
| Merlin--rapid analysis of dense genetic maps using sparse gene flow trees | Q27860829 | ||
| A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity | Q28206459 | ||
| Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-interacting protein | Q28272882 | ||
| Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2 | Q28507813 | ||
| Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results | Q29547377 | ||
| Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies | Q29614926 | ||
| PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data | Q29614933 | ||
| Multipoint quantitative-trait linkage analysis in general pedigrees | Q29614967 | ||
| A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies. | Q30425302 | ||
| Heritability of lung disease severity in cystic fibrosis | Q30441770 | ||
| Celsius: a community resource for Affymetrix microarray data | Q33287798 | ||
| A genome-wide investigation of SNPs and CNVs in schizophrenia | Q33406258 | ||
| A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. | Q33419815 | ||
| A genome-wide association study of pulmonary function measures in the Framingham Heart Study | Q33419839 | ||
| Disease gene characterization through large-scale co-expression analysis | Q33521690 | ||
| Were genome-wide linkage studies a waste of time? Exploiting candidate regions within genome-wide association studies | Q33612076 | ||
| Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
| The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades | Q33939002 | ||
| Large upward bias in estimation of locus-specific effects from genomewide scans | Q34044873 | ||
| Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung | Q34160084 | ||
| Molecular biology of the Ets family of transcription factors | Q34174026 | ||
| Understanding the population structure of North American patients with cystic fibrosis | Q34367715 | ||
| Using linkage genome scans to improve power of association in genome scans | Q34398834 | ||
| In silico method for inferring genotypes in pedigrees | Q34421334 | ||
| Advanced methods in meta-analysis: multivariate approach and meta-regression. | Q34523076 | ||
| Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor | Q34995795 | ||
| Complex two-gene modulation of lung disease severity in children with cystic fibrosis. | Q36470476 | ||
| Family-based association tests for genomewide association scans | Q36492206 | ||
| Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation | Q36672197 | ||
| Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis | Q37806449 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| genome-wide association study | Q1098876 | ||
| P304 | page(s) | 539-546 | |
| P577 | publication date | 2011-05-22 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. | |
| P478 | volume | 43 |
| Q36066687 | A Joint Location-Scale Test Improves Power to Detect Associated SNPs, Gene Sets, and Pathways |
| Q28727907 | A genome-wide analysis of open chromatin in human tracheal epithelial cells reveals novel candidate regulatory elements for lung function |
| Q46885477 | A pair of homoeolog ClpP5 genes underlies a virescent yellow-like mutant and its modifier in maize |
| Q88152316 | A transcription factor network represses CFTR gene expression in airway epithelial cells |
| Q27931694 | A yeast phenomic model for the gene interaction network modulating CFTR-ΔF508 protein biogenesis. |
| Q34364298 | AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis |
| Q89223942 | AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations |
| Q35020478 | Accurate measurement of gene copy number for human alpha-defensin DEFA1A3. |
| Q38602344 | Airway Mucosal Host Defense is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity |
| Q53532889 | Alleles versus mutations: Understanding the evolution of genetic architecture requires a molecular perspective on allelic origins. |
| Q38829205 | Are genetic polymorphisms in the renin-angiotensin-aldosterone system associated with essential hypertension? Evidence from genome-wide association studies |
| Q36676989 | Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans |
| Q89216487 | Brain arteriovenous malformations |
| Q35370064 | Can genomics help usher schizophrenia into the age of RDoC and DSM-6? |
| Q64075894 | Cell-Selective Regulation of CFTR Gene Expression: Relevance to Gene Editing Therapeutics |
| Q37316972 | Clinical and molecular characterization of the potential CF disease modifier syntaxin 1A. |
| Q38815316 | Computation of ancestry scores with mixed families and unrelated individuals |
| Q90307943 | Coordinate regulation of ELF5 and EHF at the chr11p13 CF modifier region |
| Q35592262 | Coupling technique of random amplified polymorphic DNA and nanoelectrochemical sensor for mapping pancreatic cancer genetic fingerprint |
| Q38874414 | Cystic Fibrosis Lung Immunity: The Role of the Macrophage |
| Q89219005 | Cystic fibrosis |
| Q40341616 | Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics. |
| Q38268916 | Cystic fibrosis genetics: from molecular understanding to clinical application |
| Q84355646 | Cystic fibrosis papers of the year 2010-2011 |
| Q38973292 | Cystic fibrosis: a clinical view |
| Q38865602 | Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein |
| Q36370820 | Discover hidden splicing variations by mapping personal transcriptomes to personal genomes. |
| Q38233032 | Disease-modifying genes and monogenic disorders: experience in cystic fibrosis |
| Q58696663 | ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer |
| Q91971619 | Electronic health record phenotypes associated with genetically regulated expression of CFTR and application to cystic fibrosis |
| Q28646036 | Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members |
| Q38679109 | Epithelial Sodium Channel ENaC is a Modifier of the Long Term Non-progressive Phenotype Associated with F508del CFTR Mutations |
| Q38705271 | Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease |
| Q34711894 | Ets homologous factor regulates pathways controlling response to injury in airway epithelial cells |
| Q51532878 | Evaluation of allele frequency estimation using pooled sequencing data simulation. |
| Q33646755 | Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study |
| Q35654397 | Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis |
| Q34274291 | Exome sequencing generates high quality data in non-target regions |
| Q30452653 | Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis |
| Q64863642 | Exploring genetic modifiers of Gaucher disease: The next horizon |
| Q34490196 | Expression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells |
| Q38051325 | Functional Rescue of F508del-CFTR Using Small Molecule Correctors |
| Q24294349 | Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell death |
| Q21133782 | Functional identification of APIP as human mtnB, a key enzyme in the methionine salvage pathway |
| Q35988949 | Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report |
| Q35059369 | Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypes |
| Q34036651 | Generation of Lung Epithelium from Pluripotent Stem Cells |
| Q37400152 | Genetic architecture of human fibrotic diseases: disease risk and disease progression |
| Q64102762 | Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci |
| Q36785547 | Genetic influences on cystic fibrosis lung disease severity |
| Q37193385 | Genetic modifiers of cystic fibrosis-related diabetes |
| Q36398331 | Genetic modifiers of nutritional status in cystic fibrosis |
| Q33645546 | Genetic variation and clinical heterogeneity in cystic fibrosis |
| Q35921257 | Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction. |
| Q37596109 | Genome reference and sequence variation in the large repetitive central exon of human MUC5AC. |
| Q29416995 | Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease |
| Q36108378 | Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis |
| Q37102310 | Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients |
| Q35176964 | Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma |
| Q59356004 | Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes |
| Q30912838 | Hypothesis testing at the extremes: fast and robust association for high-throughput data |
| Q36686765 | Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis |
| Q90426285 | Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics |
| Q34689530 | Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients |
| Q48239595 | Latest in cystic fibrosis. |
| Q38728512 | Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels. |
| Q37945665 | Link between CFTR mutations and ABPA: a systematic review and meta-analysis |
| Q34319603 | Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association |
| Q91588752 | Longitudinal analysis of epigenome-wide DNA methylation reveals novel smoking-related loci in African Americans |
| Q35947630 | Matrix eQTL: ultra fast eQTL analysis via large matrix operations |
| Q35208307 | Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis |
| Q34131659 | Melanocortin 3 receptor has a 5' exon that directs translation of apically localized protein from the second in-frame ATG. |
| Q35914614 | Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis |
| Q50096305 | Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis. |
| Q34236664 | Modifier genes and the plasticity of genetic networks in mice |
| Q31037017 | Mucin variable number tandem repeat polymorphisms and severity of cystic fibrosis lung disease: significant association with MUC5AC. |
| Q30426239 | Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis |
| Q42410981 | New challenges in the diagnosis and management of cystic fibrosis |
| Q84198335 | New modifier loci in cystic fibrosis |
| Q35286065 | Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients. |
| Q37072396 | Novel variation at chr11p13 associated with cystic fibrosis lung disease severity. |
| Q30986279 | Pathway analysis for RNA-Seq data using a score-based approach |
| Q35108743 | PharmGKB summary: very important pharmacogene information for CFTR |
| Q58697833 | Physiological and Pathophysiological Relevance of the Anion Transporter Slc26a9 in Multiple Organs |
| Q41553158 | Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis |
| Q49284664 | Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis. |
| Q57172314 | Recent advances in developing therapeutics for cystic fibrosis |
| Q36462832 | Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis |
| Q41629928 | Regulatory dynamics of 11p13 suggest a role for EHF in modifying CF lung disease severity |
| Q35640065 | Resolving the variable genome and epigenome in human disease. |
| Q38758711 | Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770 |
| Q36549113 | Role of Exchange Protein Activated by cAMP 1 in Regulating Rates of Microtubule Formation in Cystic Fibrosis Epithelial Cells |
| Q57486621 | Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis |
| Q47141716 | SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells |
| Q47430496 | Single nucleotide polymorphisms related to cystic fibrosis in chronic rhinositus-a pilot study |
| Q37469191 | Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. |
| Q38922232 | Small-scale high-throughput sequencing-based identification of new therapeutic tools in cystic fibrosis |
| Q57807703 | Smoking induces coordinated DNA methylation and gene expression changes in adipose tissue with consequences for metabolic health |
| Q48213703 | Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis |
| Q34149185 | Space Time Clustering and the Permutation Moments of Quadratic Form |
| Q41302801 | Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis |
| Q27681079 | Structural and biochemical basis for the inhibition of cell death by APIP, a methionine salvage enzyme |
| Q52953280 | The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. |
| Q38839806 | The CF-modifying gene EHF promotes p.Phe508del-CFTR residual function by altering protein glycosylation and trafficking in epithelial cells |
| Q26799765 | The Contribution of the Airway Epithelial Cell to Host Defense |
| Q33365189 | The background puzzle: how identical mutations in the same gene lead to different disease symptoms |
| Q36526522 | The influence of genetics on cystic fibrosis phenotypes |
| Q41533194 | Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity |
| Q38458352 | Translating the genetics of cystic fibrosis to personalized medicine |
| Q44314873 | Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities |
| Q60947300 | Variable Responses to CFTR Correctors : Estimating the Design Effect in Precision Medicine |
| Q90334316 | Variant classifications, databases and genotype-phenotype correlations |
| Q35934114 | Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis. |
| Q50090344 | Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis. |
| Q34205956 | Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis. |
| Q57433744 | Visualization of robust L1PCA |
| Q84341376 | [Genetics and modifier genes, atypical and rare forms] |
| Q36901906 | miR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors |
Search more.